Multiple inflammatory and cartilage metabolism pathways

Multiple inflammatory and cartilage metabolism pathways refers to a complex network of biological signaling cascades and metabolic processes rather than a single molecular target. These pathways are central to the pathogenesis of degenerative joint diseases like osteoarthritis, where an imbalance between anabolic and catabolic activities leads to progressive cartilage degradation (Goldring & Berenbaum, 2015, Osteoarthritis: pathology, diagnosis, and management). Key components include the NF-κB and MAPK signaling pathways, which are activated by mechanical stress or biochemical triggers to induce the expression of pro-inflammatory cytokines such as IL-1β and TNF-α (Rigoglou & Papavassiliou, 2013, The NF-κB signalling pathway in osteoarthritis). These cytokines subsequently drive the production of matrix-degrading enzymes, including matrix metalloproteinases (MMPs) and ADAMTS, which break down the extracellular matrix (Jerosch, 2011, Effects of Glucosamine and Chondroitin Sulfate on Cartilage Metabolism in OA). Therapeutic strategies targeting these pathways often involve pleiotropic agents like glucosamine or chondroitin sulfate, which aim to suppress inflammation and promote the synthesis of cartilage components (Henrotin et al., 2012, Is there any scientific evidence for the use of glucosamine in the management of osteoarthritis?). Because this term encompasses a broad array of distinct proteins and receptors, it is classified as a pathway-level description rather than a discrete therapeutic target.

Other names

Cartilage metabolism signalingInflammatory joint pathwaysOA-related signaling cascades

Simultaneous modulation of multiple signaling nodes (e.g., NF-κB, MAPK, PI3K/Akt) to reduce pro-inflammatory cytokine production and inhibit the activity of matrix-degrading enzymes.